Egetis Therapeutics AB (OSTO:EGTX) YoY Rev. per Sh. Growth : -34.69% (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Egetis Therapeutics AB YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Egetis Therapeutics AB's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was -34.69%.

Egetis Therapeutics AB's Revenue per Share for the three months ended in Sep. 2024 was kr0.03.

Egetis Therapeutics AB YoY Rev. per Sh. Growth Historical Data

The historical data trend for Egetis Therapeutics AB's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB YoY Rev. per Sh. Growth Chart

Egetis Therapeutics AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

179.96

-62.24

-61.55

-45.54

91.38

Egetis Therapeutics AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															104.17	229.41	46.43	100.00	-34.69

Egetis Therapeutics AB YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Egetis Therapeutics AB's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(0.222	-	0.116)	/	\| 0.116 \|
=	91.38 %

Egetis Therapeutics AB's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=	(Revenue per Share (Q: Sep. 2024 )	-	Revenue per Share (Q: Sep. 2023 ))	/	\| Revenue per Share (Q: Sep. 2023 )) \|
=	(0.032	-	0.049)	/	\| 0.049 \|
=	-34.69 %

Egetis Therapeutics AB YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Egetis Therapeutics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (OSTO:EGTX) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

0ABW:UK P0F:Germany

Address

Grev Turegatan 11 C, Stockholm, SWE, 114 46

Website

https://www.egetis.com

Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines